FindTrial
Sign In

Trapeziometacarpal Cartilage imaging in osteoarthritis: feasibility of 7 Tesla Magnetic Resonance Imaging and Optical Coherence Tomography

Trapeziometacarpal Cartilage imaging in osteoarthritis: feasibility of 7 Tesla Magnetic Resonance Imaging and Optical Coherence Tomography - TMC Cartilage Imaging in osteoarthritis: feasibility of 7T MRI and OCT

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37270
Enrollment
10
Registered
2013-01-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

degenerative joint disease with loss of cartilage Osteoarthritis

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age 18 years or older - Clinical symptoms of trapeziometacarpal osteoarthritis - Patients is or will be scheduled for trapeziometacarpal joint arthroplasty - Radiologic evidence for trapeziometacarpal osteoarthritis of at least stage 2 according to the Eaton-Littler classification

Exclusion criteria

Exclusion criteria: - Not able to understand the written informed consent - Contra-indications for MRI research - Contraindications for surgery - Under 18 years of age - Radiologic evidence for TMC OA, of less than stage 2 according to the Eaton-Littler classification

Design outcomes

Primary

MeasureTime frame
Visualization of TMC cartilage (degeneration) in advanced osteoarthritis using 7T MRI and OCT.—

Secondary

MeasureTime frame
Secondary study parameters are (differences in) measured cartilage thickness, cartilage volume/surface and surface fibrillation between OCT, 7T MRI and histology.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)